These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7398912)

  • 21. [Changes in the prolactin and thyrotropin content as affected by thyroliberin in patients with polycystic ovaries].
    Tudose TI; Pishulin AA; Dobracheva AD; Bobrovskaia TA
    Akush Ginekol (Mosk); 1986 Nov; (11):64-7. PubMed ID: 2949662
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Perić LA
    J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
    Parsanezhad ME; Alborzi S; Jahromi BN
    Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interference of prolactin in ovarian steroidogenesis in patients with hyperprolactinemic amenorrhea].
    Polatti F; Nava C; Zara C
    Minerva Ginecol; 1982; 34(1-2):1-6. PubMed ID: 7078820
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of metoclopramide on ovarian responsiveness to gonadotropin administration in patients with severe polycystic ovarian syndrome.
    Lissak A; Dirnfeld M; Sorokin Y; Kahana L; Abramovici H; Koch Y
    Fertil Steril; 1990 Oct; 54(4):585-9. PubMed ID: 2209878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrinological environment of polycystic ovarian disease.
    Tanaka T; Fujimoto S
    Horm Res; 1990; 33 Suppl 2():5-9. PubMed ID: 2128882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of laparoscopic multiple punch resection of the ovary on hypothalamo-pituitary axis in polycystic ovary syndrome.
    Sumioki H; Utsunomyiya T; Matsuoka K; Korenaga M; Kadota T
    Fertil Steril; 1988 Oct; 50(4):567-72. PubMed ID: 2971578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of bromocriptine (dopamine agonist) on the hypothalamo-pituitary-ovarian axis in humans].
    Aisaka K; Mori H; Kigawa M
    Horumon To Rinsho; 1983 Apr; 31(4):385-92. PubMed ID: 6883754
    [No Abstract]   [Full Text] [Related]  

  • 29. [Reaction of follicle-stimulating and luteinizing hormone to synthetic luteinizing hormone in the Stein-Leventhal syndrome].
    Vulkov I
    Akush Ginekol (Sofiia); 1976; 15(6):459-62. PubMed ID: 797267
    [No Abstract]   [Full Text] [Related]  

  • 30. Laboratory assessment of prolactin status.
    Cowden EA; Ratcliffe WA; Beastall GH; Ratcliffe JG
    Ann Clin Biochem; 1979 May; 16(3):113-21. PubMed ID: 117734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prolactin levels in women with polycystic ovary syndrome after treatment with clomiphene].
    Milewicz A; Szymczak J; Tupikowska G; Grabiński M
    Ginekol Pol; 1985 Mar; 56(3):132-7. PubMed ID: 4054664
    [No Abstract]   [Full Text] [Related]  

  • 32. Bromocriptine response in normoprolactinemic patients with polycystic ovary disease: a preliminary report.
    Seibel MM; Oskowitz S; Kamrava M; Taymor ML
    Obstet Gynecol; 1984 Aug; 64(2):213-9. PubMed ID: 6234484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin secretion in polycystic ovary syndrome (PCOS).
    Szosland K; Pawlowicz P; Lewiński A
    Neuro Endocrinol Lett; 2015; 36(1):53-8. PubMed ID: 25789595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
    Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
    Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metoclopramide stimulation in patients with benign breast disease (author's transl)].
    Maggiolo C; Cáceres E; Valdés M; Pineda G
    Rev Med Chil; 1979 Aug; 107(8):733-6. PubMed ID: 545567
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hyperprolactinemia and the polycystic ovary syndrome].
    Presl J
    Cesk Gynekol; 1981 Mar; 46(2):133-4. PubMed ID: 7237606
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dopaminergic regulation of the hypothalamo-hypophyseal system in patients with hypophyseal adenomas].
    Balabolkin MI; Gerasimov GA; Snigireva RIa; Pisarskaia IV; Liubimov AV
    Probl Endokrinol (Mosk); 1989; 35(5):3-6. PubMed ID: 2587520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered hypothalamic-pituitary function in uraemic patients [proceedings].
    Cowden EA; Ratcliffe WA; Ratcliffe JG; Dobbie JW; Kennedy AC
    J Endocrinol; 1978 Nov; 79(2):48P-49P. PubMed ID: 103991
    [No Abstract]   [Full Text] [Related]  

  • 39. [Polycystic ovary syndrome: central or peripheral disorder of regulation?].
    Szilagyi A; Rossmanith WG
    Zentralbl Gynakol; 1991; 113(15-16):851-6. PubMed ID: 1746182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Disorders of the hypothalamo-hypophyseal system as a cause of infertility in hyperprolactinemia].
    Stepanskaia NV; Ovsiannikova TV; Pshenichnikova TIa
    Acta Univ Palacki Olomuc Fac Med; 1991; 129():163-73. PubMed ID: 1837659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.